[charlesbahn]

It's a game changer for many cancers, esp breast, and a few rare genetic diseases that have led to targeted custom biologics (but at a cost of millions/patient).

Not so sure about other general ailments, maybe. It probably will develop, but determining how successful such an approach is with predicting success or failure based upon a persons genome, with say an antibiotic or a blood pressure medication, will take a ton of clinical trials with complicated statistical analysis. You also have to consider the adverse effects of the medications side of the equation, and most important, know the percentage and consequences of the algorithm recommending a wrong choice especially in time sensitive instances- like an infection.

At this point, probably best to just follow a good physicians advice on treatment choices.

Charles